Sittinger Michael, Hutmacher Dietmar W, Risbud Makarand V
Tissue Engineering Laboratory, Charité University Medicine Berlin, Germany.
Curr Opin Biotechnol. 2004 Oct;15(5):411-8. doi: 10.1016/j.copbio.2004.08.010.
Several cell-based tissue-engineering therapies are emerging to regenerate damaged tissues. These strategies use autologous cells in combination with bioresorbable delivery materials. Major functions of a delivery scaffold are to provide initial mechanical stability, homogenous three-dimensional cell distribution, improved tissue differentiation, suitable handling and properties for delivery and fixation into patients. Delivery of cells can be achieved using injectable matrices, soft scaffolds, membranes, solid load-bearing scaffolds or immunoprotective macroencapsulation. Thus, to expand the clinical potential, next generation therapies will depend on smart delivery concepts that make use of the regenerative potential of stem cells, morphogenetic growth factors and biomimetic materials.
几种基于细胞的组织工程疗法正在兴起,用于再生受损组织。这些策略使用自体细胞与生物可吸收递送材料相结合。递送支架的主要功能是提供初始机械稳定性、均匀的三维细胞分布、改善组织分化、适合递送和固定到患者体内的操作和特性。细胞递送可以通过可注射基质、软支架、膜、固体承重支架或免疫保护大胶囊来实现。因此,为了扩大临床潜力,下一代疗法将依赖于利用干细胞、形态发生生长因子和仿生材料的再生潜力的智能递送概念。